7 Einträge gefunden

1. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

   1. Bastian, Lorenz
   2. Schroeder, Michael P
   3. Eckert, Cornelia
   4. Schlee, Cornelia
   5. Tanchez, Jutta Ortiz
   6. Kämpf, Sebastian
   7. Wagner, Dimitrios L

   2019 - Forschungsinformationssystem des UKE
2. Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics

   1. Eckert, Cornelia
   2. Groeneveld-Krentz, Stefanie
   3. Kirschner-Schwabe, Renate
   4. Hagedorn, Nikola
   5. Chen-Santel, Christiane
   6. Bader, Peter
   7. Borkhardt, Arndt

   2019 - Forschungsinformationssystem des UKE
3. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

   1. Ripperger, Tim
   2. Bielack, Stefan S
   3. Borkhardt, Arndt
   4. Brecht, Ines B
   5. Burkhardt, Birgit
   6. Calaminus, Gabriele
   7. Debatin, Klaus-Michael

   2017 - Forschungsinformationssystem des UKE
4. Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial

   1. Bader, Peter
   2. Kreyenberg, Hermann
   3. von Stackelberg, Arend
   4. Eckert, Cornelia
   5. Salzmann-Manrique, Emilia
   6. Meisel, Roland
   7. Poetschger, Ulrike

   2015 - Forschungsinformationssystem des UKE
5. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

   1. Eckert, Cornelia
   2. von Stackelberg, Arend
   3. Seeger, Karl
   4. Groeneveld, Tom W L
   5. Peters, Christina
   6. Klingebiel, Thomas
   7. Borkhardt, Arndt

   2013 - Forschungsinformationssystem des UKE
6. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group

   1. Eckert, Cornelia
   2. Henze, Günter
   3. Seeger, Karlheinz
   4. Hagedorn, Nikola
   5. Mann, Georg
   6. Panzer-Grümayer, Renate
   7. Peters, Christina

   2013 - Forschungsinformationssystem des UKE
7. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

   1. Bader, Peter
   2. Kreyenberg, Hermann
   3. Henze, Günter H R
   4. Eckert, Cornelia
   5. Reising, Miriam
   6. Willasch, Andre
   7. Barth, Andrea

   2009 - Forschungsinformationssystem des UKE